Danalynn Guasteferro
Foot & Ankle Surgery · Birmingham, ALNPI 1881878296
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.1%), travel and lodging and entertainment — rather than concentrated in one kind of arrangement. Musculoskeletal Transplant Foundation Inc. accounts for 72.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $3,438 and has fallen 91.3% since, to $299 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in AL, where the typical reported total is $4,589.
Across 81 payments — averaging $57.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$3K
- Smith+Nephew$263
- AbbVie$251
- Organogenesis Inc.$224
- Osiris Therapeutics Inc.$141
- Bsn Medical Inc$119
- plus $289 from 10 others
What the payments were for
- Travel & lodging$2,15346%
- Food & beverage$2,36951%
- Entertainment$1122%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 30 | $3,347 |
| Smith+Nephew | 7 | $263 |
| AbbVie | 14 | $251 |
| Organogenesis Inc. | 10 | $224 |
| Osiris Therapeutics Inc. | 2 | $141 |
| Bsn Medical Inc | 3 | $119 |
| Hartmann USA, Inc. | 6 | $107 |
| Solventum Corporation | 1 | $28 |
| Melinta Therapeutics, LLC | 1 | $25 |
| Acera Surgical, Inc. | 1 | $22 |
| Urgo Medical North America, LLC | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $17 |
| Convatec Inc. | 1 | $17 |
| Mimedx Group, Inc. | 1 | $17 |
| Integra Lifesciences Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Stravix$259
- Grafix PL PRIME$141
- Grafix$118
- GrafixPL$118
How this compares
$4,634 in reported general payments places this provider in the 50th percentile of 40 foot & ankle surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 16 | $221 |
| Cefdinir | 11 | $217 |
| Mupirocin | 26 | $188 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Birmingham
- Norman WaldropBirmingham$3.6M
- Ashish ShahBirmingham$28K
- Swapnil SinghBirmingham$14K
- Adam LukasiewiczBirmingham$10K
- Mary GilmerBirmingham$8K
- Kenneth UngerBirmingham$4K
- Francisco CaycedoBirmingham$3K
- Ronald AgeeBirmingham$2K
- Justin DaigreDecatur$372K
- John KirchnerHoover$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.